Evaluation of dexamethasone for reduction of postsurgical sequelae of third molar removal.
Sixty patients with bilaterally symmetrical impacted third molars participated in this double-blind, within-subject study to quantify the effects of 4 mg of dexamethasone on reducing postsurgical sequelae. Each patient's surgery was staged by mouth side and completed in two appointments 5 to 6 weeks apart. A preoperative dose of dexamethasone given intravenously was randomized to mouth side and surgical appointment; sterile water served as a control. Major areas assessed in this study were facial swelling, pain, and trismus. No difference in swelling and daily pain was noted. However, trismus and global pain were significantly affected by the steroid. Patients had a daily postsurgical increase in incisal opening of 4 to 6 mm over the control side during the examination period. Patients evaluated pain by choosing the least painful side. By a greater than 4:1 margin, patients chose the steroid side as the least painful side. No increase in the rate or type of complications was detected between control and steroid sides.
Neupert
E A
EA
Oral and Maxillofacial Surgery Department, Naval Hospital, Portsmouth, VA.
Lee
J W
JW
Philput
C B
CB
Gordon
J R
JR
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D003907:Dexamethasone / Q000008:administration & dosage*; D004487:Edema / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008964:Molar, Third / Q000601:surgery*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy*; D014081:Tooth Extraction / Q000009:adverse effects*; D014313:Trismus / Q000188:drug therapy
D003907:Dexamethasone